Clinical Oncology
Volume 22, Issue 7 , Pages 526-532 , September 2010

Utilisation of Radiotherapy in Rural and Urban Areas in British Columbia Compared with Evidence-based Estimates of Radiotherapy Needs for Patients with Breast, Prostate and Lung Cancer

  • S. Tyldesley

      Affiliations

    • Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    • Corresponding Author InformationAuthor for correspondence: S. Tyldesley, Vancouver Cancer Clinic, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6. Tel: +1-604-877-6000 local 2665; Fax: +1-604-877-0505.
    • ,
  • C. McGahan

      Affiliations

    • Department of Population Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Received 22 December 2009 ,Revised 21 April 2010 ,Accepted 6 June 2010.

References 

  1. Intersociety Council for Radiation Oncology. Radiation oncology in integrated cancer management. Report to the Director of the National Cancer Institute. Washington, DC; 1991.
  2. Cleton FJ, Coebergh JWW. Cancer in the Netherlands. Dordrecht: Kluwer; 1991;
  3. Tyldesley S, Boyd C, Schulze K, et al. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys. 2001;49(4):973–985
  4. Foroudi F, Tyldesley S, Walker H, et al. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys. 2002;53(5):1240–1253
  5. Foroudi F, Tyldesley S, Barbera L, et al. Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys. 2003;55(1):51–63
  6. Barbera L, Zhang-Salomons J, Huang J, et al. Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach. Med Care. 2003;41(9):1074–1085
  7. Kerba M, Miao Q, Zhang-Salomons J, et al. Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach. Clin Oncol (R Coll Radiol). 2007;19(7):481–489
  8. Kerba M, Miao Q, Mackillop W. Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach. Radiother Oncol. 2006;80(1):S1–S2[abstract]
  9. Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence. Cancer. 2003;98(9):1977–1986
  10. Delaney G, Barton M, Jacob S, et al. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol. 2003;4(2):120–128
  11. Delaney G, Jacob S, Barton M. Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies. Cancer. 2005;103(3):462–473
  12. Mackillop WJ, Groome PA, Zhang-Solomons J, et al. Does a centralized radiotherapy system provide adequate access to care?. J Clin Oncol. 1997;15(3):1261–1271
  13. Barton M. Radiotherapy utilization in New South Wales from 1996 to 1998. Australas Radiol. 2000;44:308–314
  14. Moller TR, Brorsson B, Ceberg J, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol. 2003;42(5–6):387–410
  15. Tyldesley S, Mackillop W, Delaney G, et al. Comparison of model estimates of radiotherapy needs with utilization data from British Columbia. Int J Radiat Oncol Biol Phys. 2007;69(Suppl. 1):abstract 2543
  16. French JG, McGahan C, Duncan G, et al. Inequities in access – how geography impacts utilization of palliative radiation therapy in British Columbia. J Med Imaging Radiat Sci. 2008;39(2):75–80
  17. British Columbia Automobile Association Trip Tik© Travel Planner . Available at: http://ww2.aaa.com/scripts/WebObjects.dll/AAAOnline?association=CAA&club=273&page=ITTServicesAccessed October 2009
  18. Hislop TG, Olivotto IA, Coldman AJ, et al. Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia. Can J Public Health. 1996;87(6):390–394
  19. Goel V, Olivotto I, Hislop TG, et al. Patterns of initial management of node-negative breast cancer in two Canadian provinces. Can Med Assoc J. 1997;156(1):25–29
  20. Tyldesley S, Roques TW, Erridge S. General practitioner assessment of stage and performance status in lung cancer patients at a population level: implications for prognosis and radiotherapy needs analyses. Lung Cancer. 2007;57:381–388
  21. Wong ST, Regan S. Patient perspectives on primary health care in rural communities: effects of geography on access, continuity and efficiency. Rural Remote Health. 2009;9(1):1142
  22. Tate PS, McGee EM, Hopkins SF, et al. Breast conservation versus mastectomy: patient preferences in a community practice in Kentucky. J Surg Oncol. 1993;52(4):213–216
  23. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy. New Engl J Med. 1997;337:949–955
  24. Widmark A, Klepp O, Solberg A, et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009;373:301–308

☆ Presented in part at the annual meeting of the Canadian Association of Radiation Oncology, Quebec City, Canada, 30 September 2009.

PII: S0936-6555(10)00203-7

doi: 10.1016/j.clon.2010.06.006

Clinical Oncology
Volume 22, Issue 7 , Pages 526-532 , September 2010

Article Tools

* Image Usage & Resolution